Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
The American Journal of Drug and Alcohol Abuse|January 20, 2012
Impaired cognitive performance in subjects with methamphetamine dependence during exposure to neutral versus methamphetamine-related cuesBryan K Tolliver, Kimber L Price, Nathaniel L Baker, et al.
Drug and Alcohol Dependence|September 4, 2009
Reactivity to laboratory stress provocation predicts relapse to cocaineSudie E Back, Karen Hartwell, Stacia M DeSantis, et al.
Drug and Alcohol Dependence|May 17, 2017
Comparing adult cannabis treatment-seekers enrolled in a clinical trial with national samples of cannabis users in the United StatesErin A McClure, Jacqueline S King, Aimee Wahle, et al.
Psychoneuroendocrinology|March 7, 2008
Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocationSudie E Back, Angela E Waldrop, Michael E Saladin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
Behavioral and Functional Neuroimaging Effects of Delivering a Course of Repetitive Transcranial Magnetic Stimulation to Personalized Targets Within the Ventrolateral Or Dorsolateral Prefrontal Cortex in Treatment-Seeking Participants with Cannabis Use DisorderDaniel McCalley, Brendan Wong, Andrew Geoly, et al.
Psychoneuroendocrinology|October 16, 2024
Oxytocin moderates fMRI connectivity and response to implicit threat processing in cocaine use disorderKyle P Blidy, Nicholas Bustos, Jennifer Spalten, et al.
Medrxiv : the Preprint Server for Health Sciences|July 28, 2023
A Preliminary Investigation Of Repetitive Transcranial Magnetic Stimulation Applied To The Left Dorsolateral Prefrontal Cortex In Treatment Seeking Participants With Cannabis Use DisorderGregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
Drug and Alcohol Dependence|December 3, 2023
A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorderGregory L Sahlem, Bohye Kim, Nathaniel L Baker, et al.
Contemporary Clinical Trials|September 3, 2014
Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials NetworkErin A McClure, Susan C Sonne, Theresa Winhusen, et al.
Drug and Alcohol Dependence|June 18, 2017
A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adultsKevin M Gray, Susan C Sonne, Erin A McClure, et al.
Pageof 12